BECTON, DICKINSON AND COMPANY Payments to Acquire Investments
BECTON, DICKINSON AND COMPANY (BDX) reported Payments to Acquire Investments of $421.00 million for the 12-month period ending 2024-09-30, per its 10-K filed 2024-11-27.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2024-11-27
- BECTON, DICKINSON AND COMPANY payments to acquire investments for the quarter ending 2024-09-30 was -$409.00M.
- BECTON, DICKINSON AND COMPANY payments to acquire investments for the quarter ending 2024-06-30 was $15.00M.
- BECTON, DICKINSON AND COMPANY payments to acquire investments for the quarter ending 2023-09-30 was $0.00.
- BECTON, DICKINSON AND COMPANY payments to acquire investments for the quarter ending 2023-06-30 was $0.00.
- BECTON, DICKINSON AND COMPANY payments to acquire investments for fiscal 2024 was $421.00M.
- BECTON, DICKINSON AND COMPANY payments to acquire investments for fiscal 2023 was $0.00.
- BECTON, DICKINSON AND COMPANY payments to acquire investments for fiscal 2022 was $0.00.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$409.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | -$394.00M derived: sum of 2 quarters · filed 2024-11-27 | $421.00M 10-K · filed 2024-11-27 | |
| 2024-06-30 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-01 | $830.00M 10-Q · filed 2024-08-01 | ||
| 2024-03-31 | $815.00M 10-Q · filed 2024-05-02 | |||
| 2023-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | $0.00 derived: sum of 2 quarters · filed 2024-11-27 | $0.00 10-K · filed 2024-11-27 | |
| 2023-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | |||
| 2022-09-30 | $0.00 10-K · filed 2024-11-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |